Literature DB >> 15978010

Dopaminergic regulation of orexin neurons.

Michael Bubser1, Jim R Fadel, Lela L Jackson, James H Meador-Woodruff, Deqiang Jing, Ariel Y Deutch.   

Abstract

Orexin/hypocretin neurons in the lateral hypothalamus and adjacent perifornical area (LH/PFA) innervate midbrain dopamine (DA) neurons that project to corticolimbic sites and subserve psychostimulant-induced locomotor activity. However, it is not known whether dopamine neurons in turn regulate the activity of orexin cells. We examined the ability of dopamine agonists to activate orexin neurons in the rat, as reflected by induction of Fos. The mixed dopamine agonist apomorphine increased Fos expression in orexin cells, with a greater effect on orexin neurons located medial to the fornix. Both the selective D1-like agonist, A-77636, and the D2-like agonist, quinpirole, also induced Fos in orexin cells, suggesting that stimulation of either receptor subtype is sufficient to activate orexin neurons. Consistent with this finding, combined SCH 23390 (D1 antagonist)-haloperidol (D2 antagonist) pretreatment blocked apomorphine-induced activation of medial as well as lateral orexin neurons; in contrast, pretreatment with either the D1-like or D2-like antagonists alone did not attenuate apomorphine-induced activation of medial orexin cells. In situ hybridization histochemistry revealed that LH/PFA cells rarely express mRNAs encoding dopamine receptors, suggesting that orexin cells are transsynaptically activated by apomorphine. We therefore lesioned the nucleus accumbens, a site known to regulate orexin cells, but this treatment did not alter apomorphine-elicited activation of medial or lateral orexin neurons. Interestingly, apomorphine failed to activate orexin cells in isoflurane-anaesthetized animals. These data suggest that apomorphine-induced arousal but not accumbens-mediated hyperactivity is required for dopamine to transsynaptically activate orexin neurons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978010     DOI: 10.1111/j.1460-9568.2005.04121.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  30 in total

1.  Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.

Authors:  Bonnie G Garcia; M Diana Neely; Ariel Y Deutch
Journal:  Cereb Cortex       Date:  2010-01-29       Impact factor: 5.357

2.  Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus.

Authors:  Irene Morganstern; Guo-Q Chang; Jessica R Barson; Zhiyu Ye; Olga Karatayev; Sarah F Leibowitz
Journal:  Alcohol Clin Exp Res       Date:  2010-03-10       Impact factor: 3.455

Review 3.  Addiction and arousal: alternative roles of hypothalamic peptides.

Authors:  Luis de Lecea; Barbara E Jones; Benjamin Boutrel; Stephanie L Borgland; Seiji Nishino; Michael Bubser; Ralph DiLeone
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

Review 4.  Drugs for sleep disorders: mechanisms and therapeutic prospects.

Authors:  Elemer Szabadi
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

5.  The orexin-1 receptor antagonist SB-334867 decreases sympathetic responses to a moderate dose of methamphetamine and stress.

Authors:  Daniel E Rusyniak; Dmitry V Zaretsky; Maria V Zaretskaia; Pamela J Durant; Joseph A DiMicco
Journal:  Physiol Behav       Date:  2012-02-14

Review 6.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

7.  Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100.

Authors:  Nellie E Byun; Michael Grannan; Michael Bubser; Robert L Barry; Analisa Thompson; John Rosanelli; Raajaram Gowrishankar; Nathaniel D Kelm; Stephen Damon; Thomas M Bridges; Bruce J Melancon; James C Tarr; John T Brogan; Malcolm J Avison; Ariel Y Deutch; Jürgen Wess; Michael R Wood; Craig W Lindsley; John C Gore; P Jeffrey Conn; Carrie K Jones
Journal:  Neuropsychopharmacology       Date:  2014-01-20       Impact factor: 7.853

Review 8.  Orexin/Hypocretin System: Role in Food and Drug Overconsumption.

Authors:  Jessica R Barson; Sarah F Leibowitz
Journal:  Int Rev Neurobiol       Date:  2017-08-08       Impact factor: 3.230

9.  Effect of dopamine D1 and D2 receptor antagonism in the lateral hypothalamus on the expression and acquisition of fructose-conditioned flavor preference in rats.

Authors:  Nicole J Amador; Francis M Rotella; Sonia Y Bernal; Danielle Malkusz; Julie A Dela Cruz; Arzman Badalia; Sean M Duenas; Maruf Hossain; Meri Gerges; Salomon Kandov; Khalid Touzani; Anthony Sclafani; Richard J Bodnar
Journal:  Brain Res       Date:  2013-11-06       Impact factor: 3.252

10.  Lateral hypothalamus dopamine D1-like receptors and glucose-conditioned flavor preferences in rats.

Authors:  Khalid Touzani; Richard J Bodnar; Anthony Sclafani
Journal:  Neurobiol Learn Mem       Date:  2009-06-16       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.